PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets.
Genome Valley is an Indian high technology business district spread across 600 km² in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for biomedical research, training and manufacturing.
Arthur D. Levinson is an American businessman and is the current chairman of Apple Inc. (2011–present) and CEO of Calico. He is the former chief executive officer (1995–2009) and chairman (1999–2014) of Genentech.
Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher has acquired other reagent, consumable, instrumentation, and service providers, including: Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), and BD Advanced Bioprocessing (2018).
Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services.
The US Market Access Center, located in Menlo Park, is a business accelerator and trade gateway into the United States for high-tech international companies. The USMAC specializes in US market entry for small to mid-sized, high-growth companies in the information and communications, clean technology, and the life sciences sectors planning to expand their marketing, sales and operations to the United States.
The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three campuses of the University of California in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.
The Ohio bioscience sector strength was ranked #4 among USA states in 2008 by Business Facilities magazine.
EnCor Biotechnology is a United States company that manufactures antibodies to neural and yeast proteins. Founded in 1999 as a spin-off from the University of Florida by Gerry Shaw, a British scientist and professor at the University of Florida, the company is based in Gainesville, Florida and markets antibody reagents originally made for research purposes, but which also have commercial value.
The San Jose BioCenter is a business incubator formed as a university foundation in 2004 and focused on the initiation and development of technology companies, with an emphasis on the life sciences industry. The BioCenter emerged from San Jose State University in an effort to revitalize an industrial area of San Jose, California. As of 2012, the BioCenter had thirty-five member (assisted) companies and twelve affiliate (supporting) companies. In addition to office space, the BioCenter provides wet laboratory facilities to member companies.
Francesco De Rubertis is a partner at medicxi, a venture capital firm with offices in London, Jersey and Geneva, having co-founded the firm in February 2016. Prior to that he was a partner at another venture capital firm, Index Ventures, having led the firm's efforts to establish its life sciences practice after joining in 1997.
BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.
Ology Bioservices is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. In 2016, the company changed their strategic focus and became a biologics contract development and manufacturing company (CDMO) specializing in the manufacturing of vaccines, monoclonal antibodies, recombinant proteins, virus and nucleic acids.
Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, Tocris Biosciences, and Novus Biologicals.
The NanKang Biotech Incubation Center (NBIC) is a biotech incubator formed by the SME Foundation of the Ministry of Economic Affairs, ROC and managed by the Development Center for Biotechnology. The incubator focuses on the initiation and development of biotech startups with an emphasis of the biotech industry including pharmaceuticals, medical devices and applied biotech. NBIC is a model incubator in biotech industry, different from the university affiliated incubator, supported by the SME Foundation. As of 2015, the incubator has 21 Class I client companies, 1 Class II, and 20 Class III. Beside office space, the incubator provides wet laboratory with instruments and facilities.
Kevin Donald Lustig is a male American scientist and entrepreneur and founder of three life science companies: the pharmaceutical company Kalypsys in 2001; the online research marketplace Scientist.com in 2007; and the non-profit lab incubator Bio, Tech and Beyond in 2013.
Alexandria Real Estate Equities, Inc. is an American real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology industries.
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in New York City, U.S.
William H.Rastetter, a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, and of Daré Bioscience, Inc. in San Diego, California. He is a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018). Rastetter is also a director of Regulus Therapeutics. He was a partner in the venture firm Venrock (2006-2013), and a trustee at Caltech (2015-2018). He has served as a director (1998-2016) and as chair of Illumina (2005-2016). He advised SVB Leerink (2014-2019) and currently advises Illumina Ventures.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
